A cost-effectiveness analysis of the first-line treatment regimens for multiple myeloma in Macao.
Kuok, Chiu Fai. === Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. === Includes bibliographical references (leaves 139-154). === Abstract and appendix also in Chinese. === Abstract --- p.i === Abstract (in Chinese) --- p.iv === Acknowledgements --- p.vi === Table of Contents --- p.vii...
Other Authors: | Kuok, Chiu Fai. |
---|---|
Format: | Others |
Language: | English Chinese |
Published: |
2009
|
Subjects: | |
Online Access: | http://library.cuhk.edu.hk/record=b5894155 http://repository.lib.cuhk.edu.hk/en/item/cuhk-326783 |
Similar Items
-
Cost-effectiveness of lenalidomide in combination with dexamethasone compared to bortezomib in combination with dexamethasone for the second-line treatment of multiple myeloma in Chile
by: Susana Aceituno, et al.
Published: (2018-06-01) -
Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
by: Chen W, et al.
Published: (2016-05-01) -
The cost of kidney dialysis in hospitals affiliated to Kurdistan University of Medical Sciences in 2016
by: Frdin Gharibi, et al.
Published: (2018-01-01) -
PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION
by: R. Yagudina, et al.
Published: (2015-03-01) -
Cost-Effectiveness Analysis of Adding Daratumumab to Bortezomib, Melphalan, and Prednisone for Untreated Multiple Myeloma
by: Yaohua Cao, et al.
Published: (2021-03-01)